A Rare Case of Multiple Hereditary Exostosis: Making The Correct Diagnosis with Triple Diagnosis
DOI:
https://doi.org/10.56260/sciena.v4i4.248Keywords:
Multiple Hereditary Exostosis, femur, osteochondromaAbstract
Background: A rare genetic disorder characterized by the development of multiple benign bone tumors called osteochondromas. This condition is primarily hereditary and follows an autosomal dominant pattern of inheritance, with mutations in the EXT1 and EXT2 genes being the most common genetic. Case report: This case report describes an 12-year-old boy with lumps in all four extremities accompanied by intermittent pain. Femur x-rays concluded MHE of the femur, tibia, and bilateral fibula. Histopathological examination shows that the cartilage tissue contains chondrocyte cells that form the cartilage cap. There is a transition of cartilage to bone trabeculae through endochondral ossification and bone marrow between the bone trabeculae. Discussion and Conclusion: MHE is a rare condition, with an incidence of approximately 1 in 50,000 to 100,000 live births. MHE is closely related to genetic mutations that occur in the EXT1, EXT2, and EXT3 genes. These genes code for enzymes involved in the biosynthesis of heparan sulfate, which is necessary for normal bone growth. Mutations in any of these genes disrupt the regulation of bone growth and lead to osteochondroma formation. Symptoms of MHE can range from mild to severe, and they tend to appear in childhood or adolescence. The main clinical manifestations include the formation of a hard lump on the bone, which can cause deformity, pain, and limitation of movement. Osteochondroma can also compress nerves or blood vessels, causing complications such as circulatory disorders or paralysis. We report a rare case emphasizing the typical morphology of multiple hereditary exostosis of the long bones to establish the final diagnosis without immunohistochemistry and molecular examination. In low-resource settings where molecular analysis is not available, histopathological examination are key tools to establish a correct diagnosis.
References
Thie Hien Ha, Thi Minh Thi Ha et al. Hereditary Multiple Exostoses: A case report and literature review. SAGE Open Medical Case Reports. 2022. SAGE Journals, New York.
Pacifici, M., & Shukunami, C. Molecular and cellular basis of hereditary multiple exostoses. 2011. Connective tissue research, 52(1), 11-18.
Porter, D. E., & Simpson, A. H. The neoplastic pathogenesis of solitary and multiple osteochondromas. 1999.The Journal of pathology, 188(2), 119-125.
Hennekam, R. C., & Shields, E. D. Hereditary multiple exostoses. 2003. Journal of medical genetics, 40(1), 1-6.
Sainio, K., Suvanto, M., & Hämäläinen, M. Modern diagnostic techniques in the evaluation of hereditary multiple exostoses: a clinical radiographic and MRI study. 2000. Journal of pediatric orthopedics, 20(6), 766-770.
Kai Tong, Hongzhe Lie, et al. Osteochondroma review of 431 patient from one medical institution in South China. Journal of Bone Oncology. 2017. p23-29. Elsevier.
Pacifici M. Hereditary multiple exostoses: new insights into pathogenesis, clinical complications, and potential treatments. Curr Osteoporos Rep. 2017;15(3):142-52.
Jennes I, Pedrini E, Zuntini M, et al. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat. 2009;30(12):1620-7.
Jones KB, Pacifici M, Hilton MJ. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research. Connect Tissue Res. 2014;55(2):80-8.
Ryckx A, Somers J, Allaert L, et al. Multiple hereditary exostoses: a review of clinical appearance and metabolic pattern. Clin Genet. 2015;88(5):425-33.
Buschges R, Moser N, Korinth MC, et al. Hereditary multiple exostoses: new insights into pathogenesis and therapeutic avenues. Orthop Rev (Pavia). 2012;4(2):e19.
WHO Classification of Tumours Editorial Board, Who Classification of Tumours Editorial. Soft Tissue and Bone Tumours. (2020) ISBN: 9789283245025 - Google Books.
Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostic, and Potential Therapeutic Strategies. 2021. Frontiers in Genetics.
Li H, Yamagata T, Mori M, et al. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1 (https://pubmed.ncbi.nlm.nih.gov/12032595/). J Hum Genet. 2002;47(5):262-5. Accessed 7/5/2022.
The MHE Research Foundation. What is MHE (Multiple Hereditary Exostoses)? (https://www.mherf.org/about-mhe) Accessed 7/5/2022.
National Center for Advancing Translation Sciences, Genetic and Rare Diseases Information Center. Hereditary Multiple Osteochondromas (https://rarediseases.info.nih.gov/diseases/7035/hereditary-multiple-osteochondromas). Accessed 7/5/2022.
Wuyts W, Schmale GA, Chansky HA, et al. Hereditary Multiple Osteochondromas (https://www.ncbi.nlm.nih.gov/books/NBK1235/). 2000 Aug 3 [Updated 2020 Aug 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Accessed 7/5/2022.
Kai Tong, Hongzhe Lie, et al. Osteochondroma review of 431 patient from one medical institution in South China. Journal of Bone Oncology. 2017. p23-29. Elsevier.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rahmi Ramadhani, Noza Hilbertina, Yenita, Tofrizal, Pamelia Mayorita, Loli Devianti, Meta Zulyati Oktora

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
